Clinical and biological markers for predicting ARDS and outcome in septic patients

Abstract Sepsis is a common cause of acute respiratory distress syndrome (ARDS) associated with a high mortality. A panel of biomarkers (BMs) to identify septic patients at risk for developing ARDS, or at high risk of death, would be of interest for selecting patients for therapeutic trials, which c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jesús Villar, Rubén Herrán-Monge, Elena González-Higueras, Miryam Prieto-González, Alfonso Ambrós, Aurelio Rodríguez-Pérez, Arturo Muriel-Bombín, Rosario Solano, Cristina Cuenca-Rubio, Anxela Vidal, Carlos Flores, Jesús M. González-Martín, M. Isabel García-Laorden, Genetics of Sepsis (GEN-SEP) Network
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/eb84a8637b1a44debce07e112513328f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:eb84a8637b1a44debce07e112513328f
record_format dspace
spelling oai:doaj.org-article:eb84a8637b1a44debce07e112513328f2021-11-28T12:15:51ZClinical and biological markers for predicting ARDS and outcome in septic patients10.1038/s41598-021-02100-w2045-2322https://doaj.org/article/eb84a8637b1a44debce07e112513328f2021-11-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-02100-whttps://doaj.org/toc/2045-2322Abstract Sepsis is a common cause of acute respiratory distress syndrome (ARDS) associated with a high mortality. A panel of biomarkers (BMs) to identify septic patients at risk for developing ARDS, or at high risk of death, would be of interest for selecting patients for therapeutic trials, which could improve ARDS diagnosis and treatment, and survival chances in sepsis and ARDS. We measured nine protein BMs by ELISA in serum from 232 adult septic patients at diagnosis (152 required invasive mechanical ventilation and 72 had ARDS). A panel including the BMs RAGE, CXCL16 and Ang-2, plus PaO2/FiO2, was good in predicting ARDS (area under the curve = 0.88 in total septic patients). Best performing panels for ICU death are related to the presence of ARDS, need for invasive mechanical ventilation, and pulmonary/extrapulmonary origin of sepsis. In all cases, the use of BMs improved the prediction by clinical markers. Our study confirms the relevance of RAGE, Ang-2, IL-1RA and SP-D, and is novel supporting the inclusion of CXCL16, in BMs panels for predicting ARDS diagnosis and ARDS and sepsis outcome.Jesús VillarRubén Herrán-MongeElena González-HiguerasMiryam Prieto-GonzálezAlfonso AmbrósAurelio Rodríguez-PérezArturo Muriel-BombínRosario SolanoCristina Cuenca-RubioAnxela VidalCarlos FloresJesús M. González-MartínM. Isabel García-LaordenGenetics of Sepsis (GEN-SEP) NetworkNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jesús Villar
Rubén Herrán-Monge
Elena González-Higueras
Miryam Prieto-González
Alfonso Ambrós
Aurelio Rodríguez-Pérez
Arturo Muriel-Bombín
Rosario Solano
Cristina Cuenca-Rubio
Anxela Vidal
Carlos Flores
Jesús M. González-Martín
M. Isabel García-Laorden
Genetics of Sepsis (GEN-SEP) Network
Clinical and biological markers for predicting ARDS and outcome in septic patients
description Abstract Sepsis is a common cause of acute respiratory distress syndrome (ARDS) associated with a high mortality. A panel of biomarkers (BMs) to identify septic patients at risk for developing ARDS, or at high risk of death, would be of interest for selecting patients for therapeutic trials, which could improve ARDS diagnosis and treatment, and survival chances in sepsis and ARDS. We measured nine protein BMs by ELISA in serum from 232 adult septic patients at diagnosis (152 required invasive mechanical ventilation and 72 had ARDS). A panel including the BMs RAGE, CXCL16 and Ang-2, plus PaO2/FiO2, was good in predicting ARDS (area under the curve = 0.88 in total septic patients). Best performing panels for ICU death are related to the presence of ARDS, need for invasive mechanical ventilation, and pulmonary/extrapulmonary origin of sepsis. In all cases, the use of BMs improved the prediction by clinical markers. Our study confirms the relevance of RAGE, Ang-2, IL-1RA and SP-D, and is novel supporting the inclusion of CXCL16, in BMs panels for predicting ARDS diagnosis and ARDS and sepsis outcome.
format article
author Jesús Villar
Rubén Herrán-Monge
Elena González-Higueras
Miryam Prieto-González
Alfonso Ambrós
Aurelio Rodríguez-Pérez
Arturo Muriel-Bombín
Rosario Solano
Cristina Cuenca-Rubio
Anxela Vidal
Carlos Flores
Jesús M. González-Martín
M. Isabel García-Laorden
Genetics of Sepsis (GEN-SEP) Network
author_facet Jesús Villar
Rubén Herrán-Monge
Elena González-Higueras
Miryam Prieto-González
Alfonso Ambrós
Aurelio Rodríguez-Pérez
Arturo Muriel-Bombín
Rosario Solano
Cristina Cuenca-Rubio
Anxela Vidal
Carlos Flores
Jesús M. González-Martín
M. Isabel García-Laorden
Genetics of Sepsis (GEN-SEP) Network
author_sort Jesús Villar
title Clinical and biological markers for predicting ARDS and outcome in septic patients
title_short Clinical and biological markers for predicting ARDS and outcome in septic patients
title_full Clinical and biological markers for predicting ARDS and outcome in septic patients
title_fullStr Clinical and biological markers for predicting ARDS and outcome in septic patients
title_full_unstemmed Clinical and biological markers for predicting ARDS and outcome in septic patients
title_sort clinical and biological markers for predicting ards and outcome in septic patients
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/eb84a8637b1a44debce07e112513328f
work_keys_str_mv AT jesusvillar clinicalandbiologicalmarkersforpredictingardsandoutcomeinsepticpatients
AT rubenherranmonge clinicalandbiologicalmarkersforpredictingardsandoutcomeinsepticpatients
AT elenagonzalezhigueras clinicalandbiologicalmarkersforpredictingardsandoutcomeinsepticpatients
AT miryamprietogonzalez clinicalandbiologicalmarkersforpredictingardsandoutcomeinsepticpatients
AT alfonsoambros clinicalandbiologicalmarkersforpredictingardsandoutcomeinsepticpatients
AT aureliorodriguezperez clinicalandbiologicalmarkersforpredictingardsandoutcomeinsepticpatients
AT arturomurielbombin clinicalandbiologicalmarkersforpredictingardsandoutcomeinsepticpatients
AT rosariosolano clinicalandbiologicalmarkersforpredictingardsandoutcomeinsepticpatients
AT cristinacuencarubio clinicalandbiologicalmarkersforpredictingardsandoutcomeinsepticpatients
AT anxelavidal clinicalandbiologicalmarkersforpredictingardsandoutcomeinsepticpatients
AT carlosflores clinicalandbiologicalmarkersforpredictingardsandoutcomeinsepticpatients
AT jesusmgonzalezmartin clinicalandbiologicalmarkersforpredictingardsandoutcomeinsepticpatients
AT misabelgarcialaorden clinicalandbiologicalmarkersforpredictingardsandoutcomeinsepticpatients
AT geneticsofsepsisgensepnetwork clinicalandbiologicalmarkersforpredictingardsandoutcomeinsepticpatients
_version_ 1718408111748808704